Chimeric antigen receptor (CAR) T-cell therapy for cancer led to better outcomes in patients with autoimmune diseases than in those without, a cohort study found. A retrospective cohort study analyzed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback